Detailed Notes on factors affecting posology
Nevertheless, There's a minority of conditions the place the therapy of EID using the ICOC chelation protocol involving DF or L1 or their mixture might not be feasible as a consequence of reduced tolerability or harmful Unwanted effects such as allergic reactions in the course of parenteral infusion of DF or toxicity such as L1 agranulocytosis (Tab